IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 82 filers reported holding IMMUNOMEDICS INC in Q3 2014. The put-call ratio across all filers is 1.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $145,000 | +49.5% | 1,700 | -38.2% | 0.01% | +42.9% |
| Q2 2020 | $97,000 | +162.2% | 2,750 | 0.0% | 0.01% | +133.3% |
| Q1 2020 | $37,000 | -36.2% | 2,750 | 0.0% | 0.00% | -25.0% |
| Q4 2019 | $58,000 | +61.1% | 2,750 | 0.0% | 0.00% | +33.3% |
| Q3 2019 | $36,000 | -5.3% | 2,750 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $38,000 | -28.3% | 2,750 | 0.0% | 0.00% | -25.0% |
| Q1 2019 | $53,000 | +35.9% | 2,750 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $39,000 | -31.6% | 2,750 | 0.0% | 0.00% | -20.0% |
| Q3 2018 | $57,000 | -12.3% | 2,750 | 0.0% | 0.01% | -16.7% |
| Q2 2018 | $65,000 | +6.6% | 2,750 | -33.7% | 0.01% | +20.0% |
| Q1 2018 | $61,000 | -9.0% | 4,150 | 0.0% | 0.01% | -16.7% |
| Q4 2017 | $67,000 | +15.5% | 4,150 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $58,000 | +3.6% | 4,150 | -34.1% | 0.01% | +20.0% |
| Q2 2017 | $56,000 | +36.6% | 6,300 | 0.0% | 0.01% | +25.0% |
| Q1 2017 | $41,000 | +115.8% | 6,300 | +18.9% | 0.00% | +100.0% |
| Q4 2016 | $19,000 | +11.8% | 5,300 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $17,000 | +41.7% | 5,300 | 0.0% | 0.00% | +100.0% |
| Q2 2016 | $12,000 | -7.7% | 5,300 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $13,000 | 0.0% | 5,300 | +23.3% | 0.00% | -50.0% |
| Q4 2015 | $13,000 | +85.7% | 4,300 | 0.0% | 0.00% | +100.0% |
| Q3 2015 | $7,000 | -58.8% | 4,300 | 0.0% | 0.00% | -50.0% |
| Q2 2015 | $17,000 | +6.2% | 4,300 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $16,000 | -23.8% | 4,300 | 0.0% | 0.00% | -33.3% |
| Q4 2014 | $21,000 | +31.2% | 4,300 | 0.0% | 0.00% | +50.0% |
| Q3 2014 | $16,000 | 0.0% | 4,300 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $16,000 | -11.1% | 4,300 | 0.0% | 0.00% | -33.3% |
| Q1 2014 | $18,000 | -10.0% | 4,300 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $20,000 | -25.9% | 4,300 | 0.0% | 0.00% | -25.0% |
| Q3 2013 | $27,000 | +17.4% | 4,300 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $23,000 | – | 4,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 10,488,076 | $92,610,000 | 11.69% |
| First Light Asset Management, LLC | 2,048,643 | $18,090,000 | 6.07% |
| Foresite Capital Management III, LLC | 1,940,850 | $17,138,000 | 5.60% |
| DAFNA Capital Management LLC | 637,700 | $5,631,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 1,600,000 | $14,128,000 | 3.95% |
| Opaleye Management Inc. | 900,000 | $7,947,000 | 3.32% |
| Ghost Tree Capital, LLC | 1,200,000 | $10,596,000 | 2.20% |
| Iguana Healthcare Management, LLC | 325,000 | $2,870,000 | 1.62% |
| Healthcare Value Capital, LLC | 100,000 | $883,000 | 1.59% |
| Palo Alto Investors LP | 3,010,466 | $26,582,000 | 1.24% |